GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fermenta Biotech Ltd (BOM:506414) » Definitions » Gross-Profit-to-Asset %

Fermenta Biotech (BOM:506414) Gross-Profit-to-Asset % : 84.75% (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Fermenta Biotech Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Fermenta Biotech's annualized Gross Profit for the quarter that ended in Dec. 2024 was ₹4,571 Mil. Fermenta Biotech's average Total Assets over the quarter that ended in Dec. 2024 was ₹5,393 Mil. Therefore, Fermenta Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 84.75%.


Fermenta Biotech Gross-Profit-to-Asset % Historical Data

The historical data trend for Fermenta Biotech's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fermenta Biotech Gross-Profit-to-Asset % Chart

Fermenta Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.96 35.01 33.40 27.58 32.18

Fermenta Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.36 32.51 35.73 51.29 84.75

Competitive Comparison of Fermenta Biotech's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Fermenta Biotech's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fermenta Biotech's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fermenta Biotech's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Fermenta Biotech's Gross-Profit-to-Asset % falls into.


;
;

Fermenta Biotech Gross-Profit-to-Asset % Calculation

Fermenta Biotech's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=1905.354/( (6365.157+5478.308)/ 2 )
=1905.354/5921.7325
=32.18 %

Fermenta Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=4570.632/( (5393.16+0)/ 1 )
=4570.632/5393.16
=84.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Fermenta Biotech Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Fermenta Biotech's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fermenta Biotech Business Description

Traded in Other Exchanges
N/A
Address
Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments that are Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.

Fermenta Biotech Headlines

No Headlines